当前位置: X-MOL 学术Trends Cardiovasc. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic.
Trends in Cardiovascular Medicine ( IF 9.3 ) Pub Date : 2020-05-28 , DOI: 10.1016/j.tcm.2020.05.004
Sarju Ganatra 1 , Sourbha S Dani 2 , Sachin Shah 2 , Aarti Asnani 3 , Tomas G Neilan 4 , Daniel Lenihan 5 , Bonnie Ky 6 , Ana Barac 7 , Salim S Hayek 8 , Monika Leja 8 , Joerg Herrmann 9 , Paaladinesh Thavendiranathan 10 , Michael Fradley 11 , Vigyan Bang 2 , Katherine Shreyder 2 , Rohan Parikh 2 , Rushin Patel 2 , Amitoj Singh 2 , Simarjeet Brar 2 , Avirup Guha 12 , Dipti Gupta 13 , Paolo Mascari 2 , Richard D Patten 2 , David M Venesy 2 , Anju Nohria 14 , Frederic S Resnic 2
Affiliation  

Patients with pre-existing cardiovascular disease and risk factors are more likely to experience adverse outcomes associated with the novel coronavirus disease-2019 (COVID-19). Additionally, consistent reports of cardiac injury and de novo cardiac complications, including possible myocarditis, arrhythmia, and heart failure in patients without prior cardiovascular disease or significant risk factors, are emerging, possibly due to an accentuated host immune response and cytokine release syndrome. As the spread of the virus increases exponentially, many patients will require medical care either for COVID-19 related or traditional cardiovascular issues. While the COVID-19 pandemic is dominating the attention of the healthcare system, there is an unmet need for a standardized approach to deal with COVID-19 associated and other traditional cardiovascular issues during this period. We provide consensus guidance for the management of various cardiovascular conditions during the ongoing COVID-19 pandemic with the goal of providing the best care to all patients and minimizing the risk of exposure to frontline healthcare workers.



中文翻译:

冠状病毒病 (COVID-19) 大流行期间心血管疾病的管理。

已有心血管疾病和危险因素的患者更有可能出现与 2019 年新型冠状病毒病 (COVID-19) 相关的不良后果。此外,关于心脏损伤和新发心脏并发症的一致报告正在出现,包括在没有既往心血管疾病或重大危险因素的患者中可能出现心肌炎、心律失常和心力衰竭,这可能是由于宿主免疫反应增强和细胞因子释放综合征所致。随着病毒传播呈指数级增长,许多患者将需要针对 COVID-19 相关问题或传统心血管问题的医疗护理。虽然 COVID-19 大流行引起了医疗保健系统的关注,但在此期间,对标准化方法来处理与 COVID-19 相关的问题和其他传统心血管问题的需求尚未得到满足。我们为当前的 COVID-19 大流行期间各种心血管疾病的管理提供共识指南,目标是为所有患者提供最好的护理,并最大限度地降低一线医护人员的暴露风险。

更新日期:2020-05-28
down
wechat
bug